Siga Technologies Inc (SIGAQ) Return on Assets ROA from the fourth quarter of 2019 to fourth quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Dec 31 2019 to Jun 30 2018 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Siga Technologies Inc  (SIGAQ)


Siga Technologies Inc's ROA from the fourth quarter of 2019 to the fourth quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Siga Technologies Inc's ROA in the fourth quarter of 2019?
Siga Technologies Inc achieved a return on average assets (ROA) of 202.66 % in its fourth quarter of 2019, this is above SIGAQ's average return on assets of 73.14%.
Siga Technologies Inc assets over the 12 months ending in its fourth quarter of 2019 are valued at $187 million

ROA decreased relative to the period ending Sep 30 2019, due to the decline in net income.

However, within the Healthcare sector 240 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2019 from to 35.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter
Y / Y Total Assets Change 54.72 % 52.49 % - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 379 377 366 360 -39
Return On Assets (TTM) 202.66 % 222.14 % 240.84 % 355.23 % -59.12 %
SIGAQ's Total Ranking # 35 # # # 37 #
Total Assets (TTM) in million 199 203 203 144 128
Seq. Total Assets Change -2.19 % -0.04 % 41.3 % 11.99 % -3.6 %
Seq. Net Income Change - - - - -

SIGAQ's 5 Years Annual ROA >> Back to SIGAQ Management Effectiveness >> Compare SIGAQ ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 84
Sector # 241
Overall # 3188

Return On Assets Statistics
High Average Low
240.84 %
73.14 %
-158.92 %
(Jun 30 2019)   (Jun 30 2015)





Financial Statements
Siga Technologies Inc's Assets $ 199 million SIGAQ's Balance sheet
Siga Technologies Inc's Income $ -5 million Quarterly SIGAQ's Income Statement
SIGAQ's Income by Division See SIGAQ's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019
FY
FY
FY
FY
Y / Y Total Assets Change - - - - -
Total Assets in million 199 0 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million -7 0 0 0 0
Annual Return On Assets -3.65 % - - - -

SIGAQ's 5 Years Annual ROA >> Back to SIGAQ Management Effectiveness >> Compare SIGAQ ROA to its Competitors



More Return On Assets Ratios
SIGAQ's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SIGAQ's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SIGAQ's Competitors
Subscribers only: Roa for Siga Technologies Inc's Suppliers
Subscribers only: Return On Assets for SIGAQ's Customers

You may also want to know
SIGAQ's Roi SIGAQ's Inventory Turnover Ratio SIGAQ's Growth Rates SIGAQ's Dividend Comparisons
SIGAQ's Profitability Ratios SIGAQ's Asset Turnover Ratio SIGAQ's Dividend Growth
SIGAQ's Roe SIGAQ's Valuation Ratios SIGAQ's Financial Strength Ratios SIGAQ's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2019, within Healthcare Sector ROA
Tuhura Biosciences Inc   321.87 %
Zomedica Corp   302.42 %
Xbiotech Inc   268.74 %
Novaccess Global Inc  261.15 %
Kaya Holdings Inc   260.14 %
Trillium Therapeutics Inc   162.25 %
Check Cap Ltd  146.74 %
Semler Scientific inc   107.70 %
Collplant Biotechnologies Ltd  103.83 %
Tenax Therapeutics Inc   95.23 %
Quoin Pharmaceuticals Ltd   78.83 %
Emerald Health Therapeutics Inc.  71.45 %
Altamira Therapeutics Ltd   70.01 %
Jounce Therapeutics inc   54.66 %
Molecular Templates Inc   51.51 %
Biovie Inc   51.11 %
Palatin Technologies Inc   46.45 %
Cnbx Pharmaceuticals Inc   46.39 %
Morphic Holding inc   44.08 %

Date modified: 2026-09-26T08:35:19+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.